News

Oncology/Hematology > Anemia PK Modulator Shows Promise in Thalassemia — In small study, mitapivat increased hemoglobin in 80% of non-transfusion-dependent patients by Mike Bassett, Staff Writer ...
Hemoglobin E diseases are most common among persons with ancestors from Southeast Asia. Affected individuals produce a smaller than normal number of red blood cells.
Microcytic anemia is characterized by smaller-than-normal red cells due to decreased production of hemoglobin. This review discusses diagnosis and treatment of thalassemia, anemia of inflammation, ...
Moreover, genetic predisposition, such as the presence of Xmnl polymorphism, 69 and the type of thalassemia, such as hemoglobin E thalassemia, 70 may determine the response to hydroxyurea treatment.
Masimo MASI recently secured FDA 510(k) clearance for expanded indications of its O3 Regional Oximetry with delta hemoglobin ...
Masimo O3®'s delta hemoglobin parameters have received FDA clearance for cerebral and somatic applications and all patient ...